Valerie Walker1, Elizabeth M Stansbridge, Damian G Griffin. 1. Department of Clinical Biochemistry, Southampton University Hospitals NHS Trust, C Level MP 6, South Block, Tremona Road, Southampton SO16 6YD, UK. valerie.walker@uhs.nhs.uk
Abstract
BACKGROUND: Because the causes of stones are uncertain, interventions to prevent recurrence have an insecure foundation. Progress depends on careful evaluation of stone formers. METHODS: A descriptive retrospective database study of 1983 men and 816 women from the Southampton stones clinic from 1990 to March 2007. Anonymized data from the first attendance were analysed using non-parametric statistical tests. RESULTS: Sex ratio (2.43:1), age (median 49 y, 2.5th-97.5th percentiles, 23-77 y men, 20-79 y women), recurrent stone formers (30%) and type of stone were similar to other centres. Women more often had a positive family history (24% versus 19% men), previous urinary infection (31% versus 5%) and structural urinary tract abnormality (14% versus 7%); more men had gout (5% versus 1%) and bladder outlet obstruction (3% versus <1%). Calcium, oxalate and uric acid excretion were increased in 43%, 17% and 22% respectively of men and 31%, 7% and 10% of women. Urinary calcium, oxalate and uric acid correlated significantly, r ranging from 0.149 to 0.311 for 24 h excretion and 0.510 to 0.695 for concentrations per litre. Twenty-two percent of men and 8% of women with normal parathyroid hormone had phosphaturia (excretion of phosphate corrected for glomerular filtration rate (TmPO4/GFR) < 0.70 mmol/L); 6% men and 1.6% women also had low plasma phosphate. Many variables correlated significantly but often weakly with age. Creatinine clearance, pH and (men) TmPO4/GFR decreased from 50 y, urine creatinine, calcium and citrate from 60 y. CONCLUSIONS: Risk factors for stones differ between men and women, change with ageing and in some may have a genetic basis. The role of phosphaturia merits further exploration.
BACKGROUND: Because the causes of stones are uncertain, interventions to prevent recurrence have an insecure foundation. Progress depends on careful evaluation of stone formers. METHODS: A descriptive retrospective database study of 1983 men and 816 women from the Southampton stones clinic from 1990 to March 2007. Anonymized data from the first attendance were analysed using non-parametric statistical tests. RESULTS: Sex ratio (2.43:1), age (median 49 y, 2.5th-97.5th percentiles, 23-77 y men, 20-79 y women), recurrent stone formers (30%) and type of stone were similar to other centres. Women more often had a positive family history (24% versus 19% men), previous urinary infection (31% versus 5%) and structural urinary tract abnormality (14% versus 7%); more men had gout (5% versus 1%) and bladder outlet obstruction (3% versus <1%). Calcium, oxalate and uric acid excretion were increased in 43%, 17% and 22% respectively of men and 31%, 7% and 10% of women. Urinary calcium, oxalate and uric acid correlated significantly, r ranging from 0.149 to 0.311 for 24 h excretion and 0.510 to 0.695 for concentrations per litre. Twenty-two percent of men and 8% of women with normal parathyroid hormone had phosphaturia (excretion of phosphate corrected for glomerular filtration rate (TmPO4/GFR) < 0.70 mmol/L); 6% men and 1.6% women also had low plasma phosphate. Many variables correlated significantly but often weakly with age. Creatinine clearance, pH and (men) TmPO4/GFR decreased from 50 y, urine creatinine, calcium and citrate from 60 y. CONCLUSIONS: Risk factors for stones differ between men and women, change with ageing and in some may have a genetic basis. The role of phosphaturia merits further exploration.
Authors: Majuran Perinpam; Erin B Ware; Jennifer A Smith; Stephen T Turner; Sharon L R Kardia; John C Lieske Journal: Urology Date: 2015-07-20 Impact factor: 2.649
Authors: Frouwke Veenstra; Sophie A C Wanten; Lise M Verhoef; Minke Ter Stal; Wing-Yee Kwok; Frank H J van den Hoogen; Marcel Flendrie; Noortje van Herwaarden Journal: Rheumatol Adv Pract Date: 2021-01-28
Authors: Joshua N Curry; Matthew Saurette; Masomeh Askari; Lei Pei; Michael B Filla; Megan R Beggs; Peter Sn Rowe; Timothy Fields; Andre J Sommer; Chizu Tanikawa; Yoichiro Kamatani; Andrew P Evan; Mehdi Totonchi; R Todd Alexander; Koichi Matsuda; Alan Sl Yu Journal: J Clin Invest Date: 2020-04-01 Impact factor: 14.808
Authors: M Reza Jabalameli; Fiona M Fitzpatrick; Roberto Colombo; Sarah A Howles; Gary Leggatt; Valerie Walker; Akira Wiberg; Edmund R S Kunji; Sarah Ennis Journal: Mol Genet Genomic Med Date: 2021-08-04 Impact factor: 2.183